| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| Other Sizes |
| Targets |
3-Nitrophenylhydrazine-13C6 hydrochloride does not have a biological target as it is a derivatization reagent and analytical standard. Its function is chemical—it reacts with carbonyl compounds (aldehydes and ketones) to form hydrazone derivatives, enabling their detection and quantification by mass spectrometry. The labeled compound is used as an internal standard for the quantification of carbonyl compounds in biological and environmental samples.
|
|---|---|
| ln Vitro |
Drug compounds have included stable heavy isotopes of carbon, hydrogen, and other elements, mostly as quantitative tracers while the drugs were being developed. Because deuteration may have an effect on a drug's pharmacokinetics and metabolic properties, it is a cause for concern [1].
The labeled compound does not possess in vitro biological activity. 3-Nitrophenylhydrazine is a derivatization reagent that is not pharmacologically active. The labeled compound is used as an analytical standard for the quantification of carbonyl compounds, not for evaluating its own biological activity. |
| ln Vivo |
3-Nitrophenylhydrazine-13C6 hydrochloride does not have in vivo biological activity and is not used for therapeutic purposes. It is used as a derivatization reagent and internal standard for the quantification of carbonyl compounds in biological and environmental samples.
|
| Enzyme Assay |
In vitro assays for 3-nitrophenylhydrazine-13C6 hydrochloride focus on its use as a derivatization reagent. A standard protocol involves reacting the compound with carbonyl compounds in samples (e.g., plasma, urine) to form hydrazone derivatives. The labeled compound is added as an internal standard before derivatization. The derivatives are analyzed by LC-MS, and quantification is performed by monitoring specific mass transitions for the labeled and unlabeled compounds.
|
| Cell Assay |
Cell-based experiments are not performed with 3-nitrophenylhydrazine-13C6 hydrochloride, as it is a derivatization reagent. The compound is used exclusively in analytical chemistry applications.
|
| Animal Protocol |
In vivo animal studies are not conducted with 3-nitrophenylhydrazine-13C6 hydrochloride. When used in metabolic studies, the labeled compound serves as an internal standard for the quantification of carbonyl compounds in biological samples.
|
| ADME/Pharmacokinetics |
Pharmacokinetic properties of 3-nitrophenylhydrazine-13C6 hydrochloride are not characterized, as it is not a drug substance. The compound is used as a derivatization reagent for analytical purposes.
|
| Toxicity/Toxicokinetics |
3-Nitrophenylhydrazine-13C6 hydrochloride may cause skin and eye irritation. Standard laboratory safety precautions should be followed when handling this compound, including the use of gloves and safety glasses.
|
| References | |
| Additional Infomation |
3-Nitrophenylhydrazine-13C6 hydrochloride is a stable isotope-labeled derivatization reagent used for the quantification of carbonyl compounds by LC-MS. It is also known as 3-nitrophenylhydrazine-¹³C₆ hydrochloride. The compound is used in analytical method development, quality control, and metabolomics studies.
|
| Molecular Formula |
13C6H8CLN3O2
|
|---|---|
| Molecular Weight |
195.56
|
| Exact Mass |
195.05
|
| CAS # |
1977535-33-3
|
| PubChem CID |
132285224
|
| Appearance |
White to light yellow solid powder
|
| Hydrogen Bond Donor Count |
3
|
| Hydrogen Bond Acceptor Count |
4
|
| Rotatable Bond Count |
1
|
| Heavy Atom Count |
12
|
| Complexity |
145
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
[13CH]1=[13CH][13C](=[13CH][13C](=[13CH]1)[N+](=O)[O-])NN.Cl
|
| InChi Key |
BKOYKMLGFFASBG-BVNCJLROSA-N
|
| InChi Code |
InChI=1S/C6H7N3O2.ClH/c7-8-5-2-1-3-6(4-5)9(10)11;/h1-4,8H,7H2;1H/i1+1,2+1,3+1,4+1,5+1,6+1;
|
| Chemical Name |
(3-nitro(1,2,3,4,5,6-13C6)cyclohexa-1,3,5-trien-1-yl)hydrazine;hydrochloride
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO: 50 mg/mL (255.68 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 1.25 mg/mL (6.39 mM) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 1.25 mg/mL (6.39 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 5.1135 mL | 25.5676 mL | 51.1352 mL | |
| 5 mM | 1.0227 mL | 5.1135 mL | 10.2270 mL | |
| 10 mM | 0.5114 mL | 2.5568 mL | 5.1135 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
